What's Happening With Centene Stock?
Centene stock (NYSE: CNC) currently trades at $73 per share, roughly 25% below its pre-inflation peak level of $97 seen in August 2022, faring much worse than its peer – Molina Healthcare stock (NYSE: MOH) – which has largely traded sideways over this period. The recent fall in CNC stock can be attributed to its updated estimate of 13 million Medicaid members by the end of this year, versus its prior estimate of 13.6 million members.
Centene's Unit Secures New Four-Year Medicaid Contract in Iowa
CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.
Here's Why Centene (CNC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Health Insurer Stocks Tumble on Medicaid Enrollment Concerns
Shares of health insurers lost ground Wednesday as executives at Centene (CNC) warned about a pullback in the number of people receiving Medicaid benefits.
Centene's Medicaid pressures weigh on stocks of major insurers
Shares of major players in the Medicaid business dropped sharply Wednesday after Centene Corp. executives spoke about ongoing tumult in the joint federal and state program.
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead
CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.
Centene Shifts an AcariaHealth Facility to Shelby Township
The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.
Manage Centene Corp. Conservatively Like They Manage Their Money
Centene Corporation is a financially healthy company but is assessed a Hold opportunity for retail value investors due to political uncertainties about government healthcare programs and lack of a dividend. Despite a positive Q2 '24 earnings report, Centene stock has exhibited high volatility and faces growth challenges. Risks for investors include reliance on government programs, potential regulatory changes, and limited growth opportunities in the healthcare sector.
Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Centene has a 10-year price return of 313.77%, almost double the 179.34% price return of the S&P 500. The company is strategically positioned in the market, and the current favorable trends serve as major growth levers. The stock is undervalued, making it a decent buy.
Why Centene (CNC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Centene Beats Estimates, Boosts Guidance on Higher Premiums, Memberships
Centene (CNC) shares jumped in intraday trading Friday as the managed care provider reported better-than-expected profit and sales and raised its guidance as its premium and services sales and members increased.
Centene (CNC) Q2 Earnings Miss on Declining Medicaid Membership
Centene's (CNC) second-quarter earnings suffer from rising operating expenses and a decline in Medicaid membership levels. Improved Marketplace membership growth partially offset the negatives.
